Christopher W. Espelin

1.0k total citations
15 papers, 829 citations indexed

About

Christopher W. Espelin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Christopher W. Espelin has authored 15 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Christopher W. Espelin's work include Fungal and yeast genetics research (6 papers), Microtubule and mitosis dynamics (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Christopher W. Espelin is often cited by papers focused on Fungal and yeast genetics research (6 papers), Microtubule and mitosis dynamics (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Christopher W. Espelin collaborates with scholars based in United States, Italy and Canada. Christopher W. Espelin's co-authors include Peter K. Sorger, Xiangwei He, Daniel R. Rines, Emily S. Gillett, Bart S. Hendriks, Thomas J. Wickham, Elena Geretti, Kenneth B. Kaplan, Kim T. Simons and Stephen C. Harrison and has published in prestigious journals such as Cell, The Journal of Cell Biology and Bioinformatics.

In The Last Decade

Christopher W. Espelin

15 papers receiving 826 citations

Peers

Countries citing papers authored by Christopher W. Espelin

Since Specialization

Citations

This map shows the geographic impact of Christopher W. Espelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Espelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Espelin more than expected).

Fields of papers citing papers by Christopher W. Espelin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher W. Espelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Espelin. The network helps show where Christopher W. Espelin may publish in the future.

Co-authorship network of co-authors of Christopher W. Espelin

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher W. Espelin. A scholar is included among the top collaborators of Christopher W. Espelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher W. Espelin. Christopher W. Espelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Title	Journal	Authors	Indexed citations
1	Anti-WISP1 (MTX-463) as a Novel Potential Therapy for Idiopathic Pulmonary Fibrosis		Gordon E. Dower, Christopher W. Espelin et al.	1
2	Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy	Molecular Cancer Therapeutics	Jose F. Ponte, Leanne Lanieri et al.	29
3	Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment	Nanomedicine Nanotechnology Biology and Medicine	Nancy Dumont, Cynthia Lavoie et al.	27
4	Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer	Cancer Research	Christopher W. Espelin, Shannon C. Leonard et al.	96
5	Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)	Molecular Cancer Therapeutics	Elena Geretti, Shannon C. Leonard et al.	51
6	Impact of Tumor HER2/ERBB2 Expression Level on HER2-Targeted Liposomal Doxorubicin-Mediated Drug Delivery: Multiple Low-Affinity Interactions Lead to a Threshold Effect	Molecular Cancer Therapeutics	Bart S. Hendriks, Stephan G. Klinz et al.	50
7	Elevated GM-CSF and IL-1β levels compromise the ability of p38MAPKinhibitors to modulate TNFα levels in the human monocytic/macrophage U937 cell line	Molecular BioSystems	Christopher W. Espelin, Peter K. Sorger et al.	10
8	Molecular Structures and Interactions in the Yeast Kinetochore	Cold Spring Harbor Symposia on Quantitative Biology	Kevin D. Corbett, Jawdat Al‐Bassam et al.	7
9	Elevated GM-CSF and IL-1beta levels compromise the ability of p38 MAPK inhibitors to modulate TNFalpha levels in the human monocytic/macrophage U937 cell line.	PubMed	Christopher W. Espelin, Peter K. Sorger et al.	4
10	DataPflex: a MATLAB-based tool for the manipulation and visualization of multidimensional datasets	Bioinformatics	Bart S. Hendriks, Christopher W. Espelin	8
11	Structural and Functional Dissection of Mif2p, a Conserved DNA-binding Kinetochore Protein	Molecular Biology of the Cell	Robert Cohen, Christopher W. Espelin et al.	73
12	Spindle checkpoint proteins and chromosome–microtubule attachment in budding yeast	The Journal of Cell Biology	Emily S. Gillett, Christopher W. Espelin et al.	153
13	Binding of the EssentialSaccharomyces cerevisiaeKinetochore Protein Ndc10p to CDEII	Molecular Biology of the Cell	Christopher W. Espelin, Kim T. Simons et al.	40
14	Molecular Analysis of Kinetochore-Microtubule Attachment in Budding Yeast	Cell	Xiangwei He, Daniel R. Rines et al.	212
15	Probing the Architecture of a Simple Kinetochore Using DNA–Protein Crosslinking	The Journal of Cell Biology	Christopher W. Espelin, Kenneth B. Kaplan et al.	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact